| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:1911.)
© 2007 American Heart Association, Inc.
Original Contributions |
From the Division of Stroke Medicine (P.M.W.B., L.J.G.), University of Nottingham, Nottingham, UK; and the Medical Statistics Unit (T.C., S.P.), London School of Hygiene and Tropical Medicine, London, UK.
Correspondence to Prof Philip M.W. Bath, Division of Stroke Medicine, University of Nottingham, D Floor, South Block, Queens Medical Centre, Nottingham, NG7 2UH UK. E-mail philip.bath{at}nottingham.ac.uk
Background and Purpose— Most large acute stroke trials have been neutral. Functional outcome is usually analyzed using a yes or no answer, eg, death or dependency versus independence. We assessed which statistical approaches are most efficient in analyzing outcomes from stroke trials.
Methods— Individual patient data from acute, rehabilitation and stroke unit trials studying the effects of interventions which alter functional outcome were assessed. Outcomes included modified Rankin Scale, Barthel Index, and "3 questions". Data were analyzed using a variety of approaches which compare 2 treatment groups. The results for each statistical test for each trial were then compared.
Results— Data from 55 datasets were obtained (47 trials, 54 173 patients). The test results differed substantially so that approaches which use the ordered nature of functional outcome data (ordinal logistic regression, t test, robust ranks test, bootstrapping the difference in mean rank) were more efficient statistically than those which collapse the data into 2 groups (
2; ANOVA, P<0.001). The findings were consistent across different types and sizes of trial and for the different measures of functional outcome.
Conclusions— When analyzing functional outcome from stroke trials, statistical tests which use the original ordered data are more efficient and more likely to yield reliable results. Suitable approaches included ordinal logistic regression, t test, and robust ranks test.
This article has been cited by other articles:
![]() |
P. M. W. Bath, R. H. Martin, Y. Palesch, D. Cotton, S. Yusuf, R. Sacco, H.-C. Diener, D. Toni, C. Estol, R. Roberts, et al. Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke: A PRoFESS Subgroup Analysis Stroke, November 1, 2009; 40(11): 3541 - 3546. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Kreiter, S. A. Mayer, G. Howard, V. Knappertz, D. Ilodigwe, M. A. Sloan, and R. L. Macdonald Sample Size Estimates for Clinical Trials of Vasospasm in Subarachnoid Hemorrhage Stroke, July 1, 2009; 40(7): 2362 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Arsava, R. Rahman, J. Rosand, J. Lu, E. E. Smith, N. S. Rost, A. B. Singhal, M. H. Lev, K. L. Furie, W. J. Koroshetz, et al. Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke Neurology, April 21, 2009; 72(16): 1403 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brown and C. S. Coffey Stroke trials: A shift to shift analysis? Neurology, April 14, 2009; 72(15): 1292 - 1293. [Full Text] [PDF] |
||||
![]() |
J. L. Saver and J. Gornbein Treatment effects for which shift or binary analyses are advantageous in acute stroke trials Neurology, April 14, 2009; 72(15): 1310 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Smith, A. Forster, J. Young, and On behalf of the Cochrane Group for information pr Cochrane review: information provision for stroke patients and their caregivers Clinical Rehabilitation, March 1, 2009; 23(3): 195 - 206. [Abstract] [PDF] |
||||
![]() |
The Optimising the Analysis of Stroke Trials (OAST Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors? Stroke, March 1, 2009; 40(3): 888 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. -H. Krarup, T. Truelsen, C. Gluud, G. Andersen, X. Zeng, J. Korv, A. Oskedra, G. Boysen, and The ExStroke Pilot Trial Group Prestroke physical activity is associated with severity and long-term outcome from first-ever stroke Neurology, October 21, 2008; 71(17): 1313 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M.W. Bath, C. Geeganage, L. J. Gray, T. Collier, and S. Pocock Use of Ordinal Outcomes in Vascular Prevention Trials: Comparison With Binary Outcomes in Published Trials * Supplemental Appendix I: Statistical Tests Compared * Supplemental Appendix II: Supplementary Analyses * Supplemental Appendix III: Results Stroke, October 1, 2008; 39(10): 2817 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M.W. Bath, C. M. Geeganage, and L. J. Gray Ordinal Reanalysis of the SHEP Trial Stroke, September 1, 2008; 39(9): e145 - e145. [Full Text] [PDF] |
||||
![]() |
S. W. Miller and Y. Y. Palesch Comments Regarding the Recent OAST Article Stroke, January 1, 2008; 39(1): e14 - e14. [Full Text] [PDF] |
||||
![]() |
P. M.W. Bath and L. J. Gray Response to Letter by Miller and Palesch Stroke, January 1, 2008; 39(1): e15 - e15. [Full Text] [PDF] |
||||
![]() |
J. L. Saver Novel End Point Analytic Techniques and Interpreting Shifts Across the Entire Range of Outcome Scales in Acute Stroke Trials Stroke, November 1, 2007; 38(11): 3055 - 3062. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |